drugset

drugset / Trial / NCT02387723

CSCC_ASC Therapy in Patients With Severe Heart Failure

NCT02387723 ↗

Phase 1 Completed 10 enrolled JKastrup

NaSingle-groupOpen-labelTreatment

Summary

The present aim is to perform at small clinical safety trial in heart failure patients with allogeneic adipose tissue derived mesenchymal stem cells.

Timeline

Start: 2014-12
Primary completion: 2015-11
Completion: 2015-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CSCC_ASC	Cell therapy	100 cells	Other

Indications